Pregnancy medication risk indicating dial

Abstract

The utility model provides a pregnancy medication risk indicating dial, and relates to the technical field of pregnancy medication. The utility model is used for solving the technical problems that the existing pregnancy medication inquiry technology is operated in three steps, the operation is more complicated, and the inquiry and calculation are more inconvenient. The pregnancy medication risk indicating dial comprises a cover upper dial, the cover upper dial is arranged on the front face of the indicating dial, a plurality of month marks are arranged on the cover upper dial, day number scale marks are arranged on the cover upper dial, a rotating shaft is arranged on the indicating dial in a rotating mode, a front face pointer is fixedly connected to the rotating shaft, and an attention period block is arranged on the rotating shaft in a rotating mode. The attention period block rotates on the rotating shaft to be adjusted to the time corresponding to the pregnancy period, the front pointer points to the current date through rotation of the rotating shaft, appropriate medication is conducted according to the region, pointed by the front pointer, of the attention period block in the current medicine sensitive period, and the effect of conveniently inquiring and calculating the pregnancy medication risk is achieved.

Description

Technical Field

[0001] The utility model provides a pregnancy medication risk indicator disk, which relates to the technical field of pregnancy medication. Background Art

[0002] The use of drugs by pregnant women is the most concerning issue for every pregnant woman. During pregnancy, the hormones in the pregnant woman's body change, and the toxicity of drugs to the fetus and the metabolic cycle of drugs must be considered. Therefore, when pregnant women use drugs, they must be careful to ensure the safety of the pregnant woman and the fetus. During the entire cycle of fetal growth and development, some drugs can easily cause fetal malformation. Therefore, the rational use of drugs during pregnancy is of great significance to ensure the safety of mother and child and maintain the normal development and healthy growth of the fetus.

[0003] At present, the analysis of drug teratogenic risk is mainly divided into three steps. The first is to determine the gestational age of the patient when taking the medicine, the second is to query the data to determine the relevant risks of drug teratogenicity, and finally to comprehensively determine the teratogenic risk of the drug based on the half-life of the drug. The above three steps of the existing technology are all operated separately. The first step is to calculate the gestational age through some small programs or some through turntables, the second step is to query the relevant instructions or related literature, and the third step is to calculate it through calculation. However, this operation is relatively complicated, the query and calculation are relatively inconvenient, and it is cumbersome for non-professionals to use.

[0004] Therefore, it is necessary to provide a pregnancy medication risk indicator that is easy to query and calculate. Utility Model Content

[0005] In order to overcome the shortcomings of the existing pregnancy medication query technology, which is divided into three steps, is relatively complicated to operate, and is relatively inconvenient to query and calculate, the utility model provides a pregnancy medication risk indicator disk that is easy to query and calculate.

[0006] In order to achieve the above-mentioned purpose, the embodiment of the utility model provides the following technical solutions: a pregnancy medication risk indicator dial, comprising a cover upper dial, a rotating shaft, a month mark, a day scale mark and a front pointer, the front side of the indicator dial is the cover upper dial, a plurality of month marks are arranged on the cover upper dial, a day scale mark is arranged on the cover upper dial, a rotating shaft is rotatably arranged on the indicator dial, a front pointer is fixedly connected to the rotating shaft, and also comprises a period block, and the period block is rotatably arranged on the rotating shaft.

[0007] Preferably, the attention period block includes modules such as the all-or-no drug period, the drug teratogenic sensitive period and the drug teratogenic low sensitivity period.

[0008] Preferably, the all-or-no drug period in the attention period block is 0-4 weeks, the drug-teratogenic sensitive period in the attention period block is 5-10 weeks, and the drug-teratogenic hyposensitive period in the attention period block is 11-40 weeks.

[0009] Preferably, the black line in the day scale represents one day, and 5, 10, 15, 20, and 25 days are marked with green lines.

[0010] Preferably, it also includes a cover chassis, a period mark, a system development module and a reverse pointer. The back of the indicator disk is the cover chassis. A plurality of period marks are arranged on the cover chassis. A system development module is arranged on the cover chassis. A reverse pointer is fixedly connected to the rotating shaft.

[0011] Preferably, the phylogenetic module includes a nervous system development block, a cardiovascular system development block, an upper limb musculoskeletal system development block, a lower limb musculoskeletal system development block, an upper lip phylogenetic block, an ear phylogenetic block, an eye phylogenetic block, a tooth phylogenetic block, a palate phylogenetic block and a reproductive system development block, which are installed in concentric circles on the cover chassis.

[0012] Preferably, each development block of the system development module is divided into three blocks: a high-risk period, a low-risk period and a no-impact period.

[0013] Compared with the prior art, the indicator dial provided by the embodiment of the utility model has the following advantages: 1. By rotating the attention period block on the rotating shaft to adjust to the corresponding time of pregnancy, and rotating the front pointer to point to the current date through the rotating shaft, appropriate medication is performed according to the current drug-sensitive period block of the attention period block pointed by the front pointer, thereby achieving the effect of convenient query and calculation of the risk of medication during pregnancy.

[0014] 2. Through the cycle mark, the reverse pointer rotates through the rotating axis to the current gestational week. According to the system development module indicated by the reverse pointer and the risk block indicated by it, reasonable and appropriate medication is carried out to achieve the effect of rational medication and avoid the side effects of drugs affecting the development and growth of the fetus. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 It is a schematic diagram of the three-dimensional structure of the front side of the utility model.

[0016] Figure 2 It is a three-dimensional structural schematic diagram of the reverse side of the utility model.

[0017] Figure 3 It is a schematic diagram of the three-dimensional explosion structure of the utility model.

[0018] Figure numbers: 1: upper plate of the cover, 101: rotation axis, 2: month mark, 3: day scale mark, 4: attention period block, 5: front pointer, 6: bottom plate of the cover, 7: period mark, 8: nervous system development block, 9: cardiovascular system development block, 10: upper limb skeletal muscle system development block, 11: lower limb skeletal muscle system development block, 12: upper lip system development block, 13: ear system development block, 14: eye system development block, 15: tooth system development block, 16: palate system development block, 17: reproductive system development block, 18: reverse pointer. DETAILED DESCRIPTION

[0019] The utility model is further described below in conjunction with the accompanying drawings and specific implementation methods.

[0020] Example 1: A pregnancy medication risk indicator disk, see Figure 1-Figure 3 As shown, it includes a cover upper disk 1, a rotating shaft 101, a month mark 2, a day scale mark 3 and a front pointer 5. The front side of the indicator disk is the cover upper disk 1. The edge of the cover upper disk 1 is circumferentially provided with 12 month marks 2. The cover upper disk 1 is circumferentially provided with a day scale mark 3. The black line in the day scale mark 3 represents one day, and 5, 10, 15, 20, and 25 days are green line marks, so as to facilitate quick calculation and query. The middle part of the indicator disk is rotatably provided with a rotating shaft 101, and the front pointer 5 is fixedly connected to the rotating shaft 101 by welding. It also includes a note period block 4. The note period block 4 is rotatably provided on the rotating shaft 101. The note period block 4 includes modules such as drug all or no period, drug teratogenic sensitive period and drug teratogenic low sensitivity period. The drug all or no period in the note period block 4 is 0-4 weeks, the drug teratogenic sensitive period in the note period block 4 is 5-10 weeks, and the drug teratogenic low sensitivity period in the note period block 4 is 11-40 weeks.

[0021] When it is necessary to know the drug-sensitive period during pregnancy, the attention period block 4 is rotated on the rotating shaft 101, and the attention period block 4 is adjusted to the corresponding time of pregnancy according to the indications of the month mark 2 and the day scale mark 3. Then the front pointer 5 is rotated through the rotating shaft 101 to point to the current date. The block of the attention period block 4 pointed by the front pointer 5 is the current drug-sensitive period, so that appropriate medication can be used.

[0022] Example 2: Based on Example 1, refer to Figure 2 and Figure 3As shown, it also includes a cover chassis 6, a period mark 7, a system development module and a reverse pointer 18. The back of the indicator disk is the cover chassis 6. 40 period marks 7 are arranged circumferentially on the edge of the cover chassis 6. A system development module is arranged on the cover chassis 6. The system development module includes a nervous system development block 8, a cardiovascular system development block 9, an upper limb skeletal muscle system development block 10, a lower limb skeletal muscle system development block 11, an upper lip system development block 12, an ear system development block 13, an eye system development block 14, a tooth system development block 15, a palate system development block 16 and a reproductive system development block 17, which are installed inwardly on the cover chassis 6 in a concentric circle. Each development block of the system development module is divided into three blocks: a high-risk period, a low-risk period and a period without influence. A reverse pointer 18 is fixedly connected to the rotating shaft 101 by welding.

[0023] When it is necessary to know whether the medication taken has an impact on the current fetal development, according to the mark of the period mark 7, the reverse pointer 18 is rotated to the current gestational week through the rotating shaft 101, and according to the module areas indicated by the reverse pointer 18, such as the nervous system development block 8, cardiovascular system development block 9, upper limb skeletal muscle system development block 10, lower limb skeletal muscle system development block 11, upper lip system development block 12, ear system development block 13, eye system development block 14, tooth system development block 15, palate system development block 16 and reproductive system development block 17, and according to the high-risk period, low-risk period and no-effect period blocks indicated by them, reasonable and appropriate medication is carried out to avoid the side effects of the used drugs affecting the development and growth of the fetus.

[0024] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the utility model, rather than to limit it. Although the utility model has been described in detail with reference to the aforementioned embodiments, ordinary technicians in this field should understand that they can still modify the technical solutions recorded in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not make the essence of the corresponding technical solution deviate from the scope of the technical solution of the embodiments of the utility model.

Claims

1. A pregnancy medication risk indicator disk, comprising a cover disk (1), a rotating shaft (101), a month mark (2), a day scale mark (3) and a front pointer (5), wherein the front of the indicator disk is the cover disk (1), a plurality of month marks (2) are arranged on the cover disk (1), a day scale mark (3) is arranged on the cover disk (1), a rotating shaft (101) is rotatably arranged on the indicator disk, and a front pointer (5) is fixedly connected to the rotating shaft (101), characterized in that: It also includes a period block (4) on which the rotation shaft (101) is rotatably provided. The period block (4) includes modules for a drug all-or-no period, a drug teratogenic sensitive period, and a drug teratogenic low-sensitivity period.

2. A pregnancy medication risk indicator disk according to claim 1, characterized in that: Note that the all or no drug period in period block (4) is 0-4 weeks, the drug teratogenic sensitivity period in period block (4) is 5-10 weeks, and the drug teratogenic hyposensitivity period in period block (4) is 11-40 weeks.

3. A pregnancy medication risk indicator disk according to claim 1, characterized in that: The black line on the day scale (3) represents one day, and the green lines represent 5, 10, 15, 20, and 25 days.

4. A pregnancy medication risk indicator disk according to claim 1, characterized in that: It also comprises a cover chassis (6), a period mark (7), a phylogeny module and a reverse pointer (18); the reverse side of the indicator disk is the cover chassis (6); a plurality of period marks (7) are arranged on the cover chassis (6); a phylogeny module is arranged on the cover chassis (6); and a reverse pointer (18) is fixedly connected to the rotating shaft (101).

5. A pregnancy medication risk indicator disk according to claim 4, characterized in that: The phylogenetic module includes a nervous system development block (8), a cardiovascular system development block (9), an upper limb musculoskeletal system development block (10), a lower limb musculoskeletal system development block (11), an upper lip phylogenetic block (12), an ear phylogenetic block (13), an eye phylogenetic block (14), a tooth phylogenetic block (15), a palate phylogenetic block (16) and a reproductive system development block (17), which are installed in a concentric circle on the cover base (6).

6. A pregnancy medication risk indicator disk according to claim 5, characterized in that: Each developmental block of the phylogenetic module is divided into three blocks: high-risk period, low-risk period and no-impact period.

Images